HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,887 | +158.6% | 88,715 | 0.0% | 0.00% | – |
| Q4 2022 | $26,641 | -66.7% | 88,715 | -43.9% | 0.00% | – |
| Q3 2022 | $80,000 | -12.1% | 158,217 | 0.0% | 0.00% | – |
| Q2 2022 | $91,000 | -55.4% | 158,217 | -0.1% | 0.00% | – |
| Q1 2022 | $204,000 | +12.7% | 158,394 | 0.0% | 0.00% | – |
| Q4 2021 | $181,000 | +33.1% | 158,394 | +77.8% | 0.00% | – |
| Q3 2021 | $136,000 | +56.3% | 89,094 | +103.3% | 0.00% | – |
| Q2 2021 | $87,000 | -2.2% | 43,824 | -9.8% | 0.00% | – |
| Q1 2021 | $89,000 | -1.1% | 48,602 | +18.7% | 0.00% | – |
| Q4 2020 | $90,000 | – | 40,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 100,089 | $114,101,000 | 0.42% |
| Ikarian Capital, LLC | 553,273 | $630,000 | 0.09% |
| Aristides Capital LLC | 49,496 | $56,000 | 0.03% |
| McAdam, LLC | 62,168 | $71,000 | 0.01% |
| Virtu Financial LLC | 49,959 | $57,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 20,479 | $23,000 | 0.00% |
| GSA CAPITAL PARTNERS LLP | 20,556 | $23,000 | 0.00% |
| JGP Wealth Management, LLC | 15,000 | $18,000 | 0.00% |
| Amplius Wealth Advisors, LLC | 10,000 | $11,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 55,599 | $63,000 | 0.00% |